One-year observational study of vildagliptin with metformin to treat type 2 diabetes mellitus in real-life Russian clinical settings.
Phase of Trial: Phase IV
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Metformin (Primary) ; Vildagliptin (Primary) ; Vildagliptin/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Primary endpoint has been met. (Number of patients achieving HbA1c of <7%)